Community-acquired pneumonia: an unfinished battle
- PMID: 22032432
- PMCID: PMC7127066
- DOI: 10.1016/j.mcna.2011.08.007
Community-acquired pneumonia: an unfinished battle
Abstract
Community-acquired pneumonia remains a common illness with substantial morbidity and mortality. Current management challenges focus on identifying the likely etiologic pathogens based on an assessment of host risk factors, while attempting to make a specific etiologic diagnosis, which is often not possible. Therapy is necessarily empiric and focuses on pneumococcus and atypical pathogens for all patients, with consideration of other pathogens based on specific patient risk factors. It is important to understand the expected response to effective therapy, and to identify and manage clinical failure at the earliest possible time point. Prevention is focused on smoking cessation and vaccination against pneumococcus and influenza.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
References
-
- Brar N.K., Niederman M.S. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011;5:61–78. - PubMed
-
- Kochanek KD, Xu J, Murphy SL, et al. Deaths: Preliminary data for 2009. National Vital Statistics Reports 59, No. 4.CDC 2011. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_04.pdf. Accessed 30, June 2011. - PubMed
-
- Heron MP, Hoyert DL, Murphy SL, et al. Deaths: Final data for 2006. National Vital Statistics Reports 57. National Center for Health Statistics2009. Available at: http://www.cdc.gov/nchs/fastats/pneumonia.htm. Accessed 10, July 2011.
-
- Fine M.J., Smith M.A., Carson C.A. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134–141. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical